Syon Capital’s Pfizer PFE Stock Holding History

Syon Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$808K	Sell	33,570 -134	-0.4%	-$3.5K	0.04%	428
2026 Q1	$946K	Sell	33,704 -1,326	-4%	-$35.3K	0.05%	324
2025 Q4	$872K	Sell	35,030 -4,097	-10%	-$103K	0.04%	348
2025 Q3	$997K	Buy	39,127 +3,898	+11%	+$96.2K	0.05%	256
2025 Q2	$854K	Sell	35,229 -15,738	-31%	-$367K	0.06%	244
2025 Q1	$1.29M	Buy	50,967 +2,348	+5%	+$61.4K	0.11%	142
2024 Q4	$1.29M	Buy	48,619 +973	+2%	+$26.4K	0.12%	129
2024 Q3	$1.38M	Sell	47,646 -4,979	-9%	-$145K	0.12%	128
2024 Q2	$1.47M	Buy	52,625 +772	+1%	+$21.3K	0.14%	112
2024 Q1	$1.44M	Sell	51,853 -12,591	-20%	-$349K	0.14%	113
2023 Q4	$1.86M	Buy	64,444 +33,961	+111%	+$1.03M	0.19%	84
2023 Q3	$1.01M	Buy	+30,483	New	+$1.08M	0.13%	104

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Syon Capital's PFE Position: Q2 2026 in Review

Syon Capital reduced its Pfizer (PFE) stake by 0.4% in Q2 2026, selling an estimated $3.5K and leaving 33,570 shares worth $808K. The position accounts for 0.04% of the portfolio, ranked #428.

Syon Capital first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.86M in Q4 2023. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Syon Capital held 33,570 shares of Pfizer worth $808K as of Q2 2026.
Syon Capital sold 134 Pfizer shares in Q2 2026, an estimated $3.5K.
Pfizer made up 0.04% of Syon Capital's portfolio in Q2 2026, its #428 holding.
Syon Capital first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
Syon Capital's Pfizer position peaked at $1.86M in Q4 2023.
2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.